New treatment shows promise for controlling severe Crohn's disease

NCT ID NCT05029921

Summary

This study tested how well and how safely the medication ustekinumab (brand name STELARA) works for Chinese adults with moderate to severe Crohn's disease. It involved 182 participants who received the treatment for one year. Researchers measured whether the drug reduced gut inflammation and symptoms like abdominal pain and diarrhea.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, 563000, China

  • Anhui Province Hospital

    Hefei, 230001, China

  • Changzhou No 2 Peoples Hospital

    Changzhou, 213000, China

  • Guangzhou First Municipal People's Hospital

    Guangzhou, 510180, China

  • Huashan Hospital Fudan University

    Shanghai, 200040, China

  • Huzhou central hospital

    Huzhou, 313099, China

  • Jiangsu Province Hospital

    Nanjing, 210029, China

  • Jinhua municipal central hospital

    Jinhua, 321000, China

  • Ningbo medical center lihuili hospital

    Ningbo, 315000, China

  • Peking University Shenzhen Hospital

    Shenzhen, 518036, China

  • Peking University Third Hospital

    Beijing, 100191, China

  • Renmin Hospital of Wuhan University

    Wuhan, 430060, China

  • Shanghai 10th Peoples Hospital

    Shanghai, 200072, China

  • Shanghai East Hospital

    Shanghai, 200120, China

  • Shengjing Hospital Of China Medical University

    Shenyang, 110004, China

  • Sir Run Run Shaw Hospital Zhejiang University School of Medicine

    Hangzhou, 310016, China

  • The First Affiliated Hospital Sun Yat sen University

    Guangzhou, 510080, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, 350005, China

  • The First Affiliated Hospital of NanChang University

    Nanchang, 330006, China

  • The Military General Hospital of Beijing PLA

    Beijing, 100700, China

  • The Second Affiliated Hospital of Zhejiang University

    Hangzhou, 310003, China

  • The Second Hospital Affiliated To Suzhou University

    Suzhou, 215168, China

  • The Sixth Affiliated Hospital of Sun Yat-sen University

    Guangzhou, China

  • The second Xiangya Hospital of Central South University

    Changsha, 200120, China

  • Tongji Hospital, Tongji Medical College of HUST

    Wuhan, 430030, China

  • West China Hospital Sichuan University

    Chengdu, 610041, China

  • Wuxi People s Hospital

    Wuxi, 214023, China

  • Yangzhou First People's Hospital

    Yangzhou, 225001, China

  • Zhongda Hospital Southeast University

    Nanjing, 210000, China

Conditions

Explore the condition pages connected to this study.